海事通用次季转盈5607万
Nanyang Thu, Dec 24, 2020 12:14am - 8 hours ago


（吉隆坡23日讯）海事通用（M&G，5078，主板交通与物流股）在2021财年次季，转亏为盈5606万5000令吉，或每股7.75仙，去年同期净亏1214万9000令吉。

该公司今日向交易所报备，因为重组收益和较低的财务费用，促使净利上升。

在截至10月底的次季，营业额年跌13.27%至4756万5000令吉，因为冠病疫情冲击原油需求量所致。

在首半年，海事通用也是转盈4108万2000令吉，上财年同期净亏2058万2000令吉；营业额年跌5.07%，至1亿286万4000令吉。

执行主席拿督莫哈末阿兹兰指，石油需求下降预计将持续到明年下半年，或直到各种刺激措施及疫苗广泛使用并推动经济复苏为止。

“不过，大马及主要贸易伙伴如中国、日本和新加坡的经济逐步开放，及疫苗的积极进展，为油气上游与下游业务在明年捎来希望。”

海事通用次季转盈5607万
Nanyang Thu, Dec 24, 2020 12:14am - 8 hours ago


（吉隆坡23日讯）海事通用（M&G，5078，主板交通与物流股）在2021财年次季，转亏为盈5606万5000令吉，或每股7.75仙，去年同期净亏1214万9000令吉。

该公司今日向交易所报备，因为重组收益和较低的财务费用，促使净利上升。

在截至10月底的次季，营业额年跌13.27%至4756万5000令吉，因为冠病疫情冲击原油需求量所致。

在首半年，海事通用也是转盈4108万2000令吉，上财年同期净亏2058万2000令吉；营业额年跌5.07%，至1亿286万4000令吉。

执行主席拿督莫哈末阿兹兰指，石油需求下降预计将持续到明年下半年，或直到各种刺激措施及疫苗广泛使用并推动经济复苏为止。

“不过，大马及主要贸易伙伴如中国、日本和新加坡的经济逐步开放，及疫苗的积极进展，为油气上游与下游业务在明年捎来希望。”

海事通用次季转盈5607万
Nanyang Thu, Dec 24, 2020 12:14am - 8 hours ago


（吉隆坡23日讯）海事通用（M&G，5078，主板交通与物流股）在2021财年次季，转亏为盈5606万5000令吉，或每股7.75仙，去年同期净亏1214万9000令吉。

该公司今日向交易所报备，因为重组收益和较低的财务费用，促使净利上升。

在截至10月底的次季，营业额年跌13.27%至4756万5000令吉，因为冠病疫情冲击原油需求量所致。

在首半年，海事通用也是转盈4108万2000令吉，上财年同期净亏2058万2000令吉；营业额年跌5.07%，至1亿286万4000令吉。

执行主席拿督莫哈末阿兹兰指，石油需求下降预计将持续到明年下半年，或直到各种刺激措施及疫苗广泛使用并推动经济复苏为止。

“不过，大马及主要贸易伙伴如中国、日本和新加坡的经济逐步开放，及疫苗的积极进展，为油气上游与下游业务在明年捎来希望。”

疫苗灌封工作未到手 狠下200万令吉投资药剂厂房 市场快讯, 焦点讯息


Share on Facebook
Share on Twitter
发马（PHARMA，7081，主板保健股）狠下200万令吉投资尚未正式接获委任为负责新冠肺炎疫苗灌封工作的公司。

2022年就能完成设立疫苗灌封生产线；2026年就能有全新疫苗制造厂房。自2018年展开项目以来，公司目前已完成1种疫苗注册。

该局已向政府提呈计划书，包括生产容量、所需容器库存与指引等。该公司每月可生产1000万剂小瓶疫苗。公司会把位于蒲种的小针剂（SVI）厂房暂时用作疫苗灌封工作，并拨出200万令吉添购特殊疫苗灌封设备与附件，以及营运投资。

发马代理董事经理莫哈末伊克巴向媒体指出，“对我国药剂公司而言，生产容量不是问题，最大挑战反而是疫苗会是抢手货，生产商能够提供多少疫苗给大马。生产国也得优先考虑内需，才分配给其他国家。我预计疫苗应会在明年首季运到大马。”

一旦接收疫苗， 发马能立即执行灌封工作，但需要一段时间得到政府批准，交货时间大约1个月。达到大马药剂监管局（NPRA）标准后，才能正式售卖。

发马替政府运送740种药物，预计会在末季拿下另29种药物的运送工作。

发马接下来会专注扩展生产，包括新冠肺炎疫苗的灌封工作，以及落实中的全球首个清真疫苗厂房计划。

该公司跨入非处方药领域，是希望将业务版图扩大至私人领域，继续投资在药物研发，计划扩大产品组合至更多非处方药（Over-thecounter）。

他谈到，由于处方药（Ethical drugs）只能由医生开药，不像非处方药般能在药剂行购买，因此发马希望能摘下“依赖政府特许经营权”的标签，扩大成长空间。

“我们的目标不是平衡公共与私人领域的营收贡献，而是希望非特许经营权业务的营收，可以超越同行。”

另一边厢，他谨慎乐观地看待公司能在末季恢复正常表现，即政府订单回到疫情爆发前水平。尽管竞争依然激烈，但药剂行业前景仍良好。

他提到，由于市场预期发马争取疫苗灌封合约将水到渠成，发马今天再次受投资者追捧，周一股价冲破5令吉大关。

发马周一以4.52令吉开盘后节节攀升，并在午盘冲上单日最高的5.33令吉，盘中涨幅为1令吉或23%。惟该股之后回吐部份涨幅，最终以8.27令吉收市，全天大涨94仙或21.71%，是今日第2大上升股，成交量有1617万股。

疫苗灌封工作未到手 狠下200万令吉投资药剂厂房
市场快讯, 焦点讯息

Share on Twitter
发马（PHARMA，7081，主板保健股）狠下200万令吉投资尚未正式接获委任为负责新冠肺炎疫苗灌封工作的公司。

2022年就能完成设立疫苗灌封生产线；2026年就能有全新疫苗制造厂房。自2018年展开项目以来，公司目前已完成1种疫苗注册。

该局已向政府提呈计划书，包括生产容量、所需容器库存与指引等。该公司每月可生产1000万剂小瓶疫苗。公司会把位于蒲种的小针剂（SVI）厂房暂时用作疫苗灌封工作，并拨出200万令吉添购特殊疫苗灌封设备与附件，以及营运投资。

发马代理董事经理莫哈末伊克巴向媒体指出，“对我国药剂公司而言，生产容量不是问题，最大挑战反而是疫苗会是抢手货，生产商能够提供多少疫苗给大马。生产国也得优先考虑内需，才分配给其他国家。我预计疫苗应会在明年首季运到大马。”

一旦接收疫苗， 发马能立即执行灌封工作，但需要一段时间得到政府批准，交货时间大约1个月。达到大马药剂监管局（NPRA）标准后，才能正式售卖。

发马替政府运送740种药物，预计会在末季拿下另29种药物的运送工作。

发马接下来会专注扩展生产，包括新冠肺炎疫苗的灌封工作，以及落实中的全球首个清真疫苗厂房计划。

该公司跨入非处方药领域，是希望将业务版图扩大至私人领域，继续投资在药物研发，计划扩大产品组合至更多非处方药（Over-thecounter）。

他谈到，由于处方药（Ethical drugs）只能由医生开药，不像非处方药般能在药剂行购买，因此发马希望能摘下“依赖政府特许经营权”的标签，扩大成长空间。

“我们的目标不是平衡公共与私人领域的营收贡献，而是希望非特许经营权业务的营收，可以超越同行。”

另一边厢，他谨慎乐观地看待公司能在末季恢复正常表现，即政府订单回到疫情爆发前水平。尽管竞争依然激烈，但药剂行业前景仍良好。

他提到，由于市场预期发马争取疫苗灌封合约将水到渠成，发马今天再次受投资者追捧，周一股价冲破5令吉大关。

发马周一以4.52令吉开盘后节节攀升，并在午盘冲上单日最高的5.33令吉，盘中涨幅为1令吉或23%。惟该股之后回吐部份涨幅，最终以8.27令吉收市，全天大涨94仙或21.71%，是今日第2大上升股，成交量有1617万股。

海事通用次季转盈5607万
Nanyang Thu, Dec 24, 2020 12:14am - 8 hours ago


（吉隆坡23日讯）海事通用（M&G，5078，主板交通与物流股）在2021财年次季，转亏为盈5606万5000令吉，或每股7.75仙，去年同期净亏1214万9000令吉。

该公司今日向交易所报备，因为重组收益和较低的财务费用，促使净利上升。

在截至10月底的次季，营业额年跌13.27%至4756万5000令吉，因为冠病疫情冲击原油需求量所致。

在首半年，海事通用也是转盈4108万2000令吉，上财年同期净亏2058万2000令吉；营业额年跌5.07%，至1亿286万4000令吉。

执行主席拿督莫哈末阿兹兰指，石油需求下降预计将持续到明年下半年，或直到各种刺激措施及疫苗广泛使用并推动经济复苏为止。

“不过，大马及主要贸易伙伴如中国、日本和新加坡的经济逐步开放，及疫苗的积极进展，为油气上游与下游业务在明年捎来希望。”

The other counters rebounded and only this worst counter remained.

Retail investors are afraid to come in.

It has just started to rise and there will be a chance to limit up tomorrow.

Leon Fuat to ride on expansion plans of manufacturers
TheEdge Wed, Dec 23, 2020 04:00pm - 26 minutes ago


A decision made last year to venture into steel pipe manufacturing is already paying off for Main Market-listed Leon Fuat Bhd, as the demand from rubber glove and logistics companies looking to expand their facilities has been robust.

Although this new business segment has yet to make a significant financial contribution, executive director Calvin Ooi Shang How is confident it will become the group’s third core business after steel trading and processing.

“With this diversification, we are providing customers with additional options in the purchase of steel pipes locally. We are of the opinion that the steel pipe manufacturing business complements our trading and processing businesses,” he tells The Edge in an interview.

Steel pipes can be used in many applications, including the manufacture of machinery, steel structural works and storage systems.

“Over the past few months, we have received positive responses from the local market. Today, we are seeing strong demand from the manufacturing industry, especially rubber glove makers, which have been expanding aggressively since the outbreak of Covid-19,” says Ooi.



Generally, manufacturers are Leon Fuat’s indirect clients as the group deals directly with distributors and wholesalers, as well as the manufacturers’ contractors and suppliers.

“Other than the established glove players in the country, many new companies are also diversifying into this [glove] sector. When these companies want to put up new manufacturing facilities, we will become an indirect beneficiary,” Ooi points out.

Leon Fuat’s three-phase steel pipe manufacturing is being undertaken at a new plant sited on a 16-acre parcel in Kawasan Perusahaan Bandar Sultan Suleiman in Port Klang, adjacent to North Port.

Excluding the land cost and RM31 million incidental cost, more than RM50 million has been allocated as capital expenditure for Phase 1, mainly for the purchase of machinery and construction of the factory. Phase 1 commenced operation at the end of 2Q2019. With a current installed capacity of about 5,000 tonnes per month, the factory is running at a utilisation rate of about 60%.

“In hindsight, the timing is just right for us because our steel pipe manufacturing plant is now up and running at a time when the glove manufacturers are expanding, not only this year but also next year. The orders are coming in strongly and we still have sufficient capacity to deliver,” says Ooi, 41, who was appointed to the board of Leon Fuat in June 2012.

He is the son of the company’s co-founder and executive deputy chairman Datuk Seri Ooi Bin Keong, and the nephew of managing director Ooi Seng Khong and executive director Ooi Kong Tiong. He is also the cousin of executive director Ng Kok Teong. The Ooi family controls more than 70% of the company through Leon Fuat Holdings Sdn Bhd.

Ooi stresses that Leon Fuat’s main objective in Phase 2 is to expand its product range, rather than just for the sake of expanding production capacity. “We intend to make steel pipes with a bigger range of sizes, allowing us to serve a wider range of customers,” he says.

“Our immediate plan for Phase 2 is to build a warehouse and common infrastructure surrounding the warehouse for about RM27 million. If and when we are ready to expand capacity, we will need to invest further.”

While Leon Fuat’s current focus is the local market, the group also plans to export its steel pipe products to overseas markets when the time is right, says Ooi. That is why the plant is located in Port Klang.

Trading and processing segments may benefit too


Ooi explains that when manufacturers expand production capacity, they will require not only steel pipes from Leon Fuat but also its processing services for customised parts. Moreover, they would need to order steel parts and materials, which benefits the group’s trading business.

The rising demand for online delivery services has been favourable to Leon Fuat as many logistics and warehouse companies are investing to improve or expand their warehouse handling facilities, including the conveyor and sorting systems, which require a lot of flat and long steel materials. Industries such as palm oil processing and refineries also require Leon Fuat’s products and services.

“We are still new in the steel pipe manufacturing business, but we do see a growing demand for steel material in the future. One of the reasons steel material is widely and continuously used in various industries is because steel is one of the most recyclable materials in the world,” says Ooi.

Over the past five financial years, Leon Fuat generated a net profit of between RM18 million and RM27 million, except for FY2017 ended Dec 31, when it was exceptionally high, and FY2019, when it was exceedingly low. Ooi says the exceptional earnings of RM79.81 million in FY2017 was due to the company recognising gains and compensati

The most failed counter will not rebound.

A lot of people lose money at this counter.

Announce the ex-rights date.
1配1附加股送3凭单 益大资源冀筹6067万


益大资源（EITA，5208，主板工业股）建议，发行1亿3000万股附加股，并在随后派送8666万6666张免费凭单。

该公司日前向交易所报备，每持有1股将获得1股附加股，除权日待定，并在随后以每持有3股比例，派送一张免费凭单；估计可在明年首季完成。

同时，凭单转换价为70仙，若全面转换，可筹得6066万6666令吉资金，将用作未来营运资本。

根据文告，这是为了奖励股东，及提高股东参与度与股票流动性。

另外，上述建议还需获得股东与马交所的批准。

Be careful! heard that EPF is selling shares.

钱都还没赚到股价起了100巴仙有点过火了。

Additional Listing Announcement /Subdivision of Shares
YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ? No
Types of corporate proposal Conversion of Preference Shares
Details of corporate proposal Issuance of ICPS 2016/2026 to Ordinary Shares
No. of shares issued under this corporate proposal 2,004,660
Issue price per share ($$) Malaysian Ringgit (MYR) 0.8000
Par Value($$) (if applicable) Malaysian Ringgit (MYR) 0.000
Latest issued share capital after the above corporate proposal in the following
Units 1,043,871,461
Issued Share Capital ($$) Malaysian Ringgit (MYR) 458,412,544.000
Listing Date 16 Dec 2020


Announcement Info
Company Name YONG TAI BERHAD
Stock Name YONGTAI
Date Announced 15 Dec 2020
Category Additional Listing Announcement /Subdivision of Shares
Reference Number ALA-04122020-00005

It will continue to rebound tomorrow.

Tomorrow will exceed 0.5.

Can buy: C57.

NTA0.53

Rush up before the market closes.

It will fly at noon.

The show time is at noon.

The chance of reaching 0.30 today is high.NTA：1.52

Continue to limit up tomorrow.

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？Topup IOIPG & IOIPG-C2

Topup IOIPG & IOIPG-C2

IOIPG bring in Sinopharm Vaccine？news out today？

After the news is announced, it will be above 0.50.

Hope to fly again next Monday.

It turned out that the winner was BENALEC (5190).

It will rise above 0.30 at noon.

Now continue to collect and wait for the news to be announced.

The price is already too high before the real news is announced.

The closing stock price will be higher than it is now.

Prices continue to increase.

It started flying again.

It may be taken over.

NTA (RM) Limit up next Monday. MENTIGA (5223) S
: 2.620

https://www.klsescreener.com/v2/announcements/view/3268553

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020
MENTIGA CORPORATION BERHAD

Financial Year End 31 Dec 2020
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2020
The figures have not been audited
Attachments
Q320 for announcement.pdf
110.9 kBQ320 notes to the account.pdf
221.4 kB
Default CurrencyOther Currency
Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020

INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2020
30 Sep 2019
30 Sep 2020
30 Sep 2019
$'000
$'000
$'000
$'000
1 Revenue
11,016
1,326
13,315
3,588
2 Profit/(loss) before tax
7,856
-2,080
2,525
-5,424
3 Profit/(loss) for the period
7,855
-2,081
2,522
-5,427
4 Profit/(loss) attributable to ordinary equity holders of the parent
7,855
-2,081
2,522
-5,427
5 Basic earnings/(loss) per share (Subunit)
10.94
-2.90
3.51
-7.56
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($)
2.6200
2.5900

NTA (RM) Limit up next Monday.
: 2.620

https://www.klsescreener.com/v2/announcements/view/3268553

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020
MENTIGA CORPORATION BERHAD

Financial Year End 31 Dec 2020
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2020
The figures have not been audited
Attachments
Q320 for announcement.pdf
110.9 kBQ320 notes to the account.pdf
221.4 kB
Default CurrencyOther Currency
Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020

INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2020
30 Sep 2019
30 Sep 2020
30 Sep 2019
$$'000
$$'000
$$'000
$$'000
1 Revenue
11,016
1,326
13,315
3,588
2 Profit/(loss) before tax
7,856
-2,080
2,525
-5,424
3 Profit/(loss) for the period
7,855
-2,081
2,522
-5,427
4 Profit/(loss) attributable to ordinary equity holders of the parent
7,855
-2,081
2,522
-5,427
5 Basic earnings/(loss) per share (Subunit)
10.94
-2.90
3.51
-7.56
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.6200
2.5900

Warrants limit up is coming. .

Usually listed as halal stocks will rise very high. .

IQGROUP (5107)heard that QR will be announced tomorrow.

IQGROUP (5107)heard that QR will be announced tomorrow.